Fig. 2From: CAFs-derived rho-associated kinase1 mediated EMT to promote laryngeal squamous cell carcinoma metastasisCAFs enhanced the ability of movement, migration and invasion of Hep2 cells via the high expression of ROCK1. (A) ROCK1 IF staining in CAFs/si-NC or CAFs/si-ROCK1 cells. ROCK1 level was reduced in Hep2/CAFs/si-ROCK1 cells. (D). The inhibition effect and CAFs associative phenotype were verified by Western Blot. ROCK1, FAP, α-SMA, FSP1, NG2 and PDGF-β levels were significantly decreased in Hep2/CAFs/si-ROCK1 cells. (E). Protein ratio in CAFs/si-NC and NFs/ROCK1 cells (*P < 0.05, **P < 0.01). (B) Hep2/CAFs/si-NC or Hep2/CAFs/si-ROCK1 cells on cell mobility as assessed via wound healing assay. Hep2/CAFs/si-ROCK1 cells decreased the mobility. (C) Wound size in Hep2/CAFs/si-NC or Hep2/CAFs/si-ROCK1 cells (*P < 0.05). (F). Hep2 cells co-cultured with CAFs/si-NC or CAFs/si-ROCK1 on cell migration and invasion as measured via trans-well assay. Hep2/CAFs/si-ROCK1 inhibit the ability of migration and invasion. (G). Cell number in every field in Hep2/NFs/vector and Hep2/CAFs/si-ROCK1 cells (*P < 0.05, **P < 0.01). (H). Plasmid transfection was used to up-regulate ROCK1 in NFs, the effect of transfection was showed via IF. (K). The expression of ROCK1 and CAFs associative phenotype were verified by Western Blot. ROCK1, FAP, α-SMA, FSP1, NG2 and PDGF-β levels were significantly increased. (L). Protein ratio in NFs/vector or NFs/ROCK1 cells (*P < 0.05, **P < 0.01). (I). Hep2/NFs/vector or Hep2/NFs/ROCK1 cells on cell mobility as assessed via wound healing assay. Hep2/NFs/ROCK1 cells increased the mobility. (J). Wound size in Hep2/CAFs or Hep2/NFs cells (**P < 0.01). (M). Hep2/NFs/vector or Hep2/NFs/ROCK1 cells on cell migration and invasion as measured via trans-well assay. Hep2/NFs/ROCK1 cells stimulated the ability of migration and invasion. (N). Cell number in every field in Hep2/NFs/vector or Hep2/NFs/ROCK1 cells (*P < 0.05, **P < 0.01)Back to article page